Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net loss	$ (10,598,515)	$ (10,820,574)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	2,400,980	300,898
Stock-based 401K company common match	35,747	19,967
Depreciation expense	4,406	11,706
Operating lease expense	180,775	106,949
Changes in operating assets and liabilities:
Prepaid expenses and other assets	(99,145)	1,935,067
Accounts payable	30,361	361,871
Accrued expenses	188,524	125,133
Restructuring reserve	0	(498,185)
Operating lease liabilities	(127,804)	(62,597)
Net cash used in operating activities	(7,984,671)	(8,519,765)
Cash flows from financing activities:
Proceeds from exercise of warrants	0	70,459
Proceeds from exercise of stock options	344,112	0
Proceeds from issuances of common stock, net of issuance costs	48,544,998	29,756,502
Net cash provided by financing activities	48,889,110	29,826,961
Net increase in cash and cash equivalents	40,904,439	21,307,196
Cash and cash equivalents at beginning of period	28,839,565	12,161,739
Cash and cash equivalents at end of period	$ 69,744,004	$ 33,468,935